Login
From:
Fragile X News Today
(Uncensored)
subscribe
FDA clears Phase 2 trial of oral SPG601 in men with fragile X
https://fragilexnewstoday.com/news/fda-clears-phase-2-trial-oral-spg601-men-fragile-x/
links
backlinks
Tagged with:
clinical trial
The FDA has approved a Phase 2 trial to test SPG601, an oral treatment candidate, in men with fragile X syndrome.
Roast topics
Find topics
Find it!
